These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 31766266

  • 1. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
    Lee KF, Tsai MM, Tsai CY, Huang CG, Ou YH, Hsieh CC, Hsieh HL, Wang CS, Lin KH.
    Int J Mol Sci; 2019 Nov 13; 20(22):. PubMed ID: 31766266
    [Abstract] [Full Text] [Related]

  • 2. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J, Shang Y, Liu S, Piao Y, Cui X, Li Y, Lin Z.
    Diagn Pathol; 2014 Mar 20; 9():67. PubMed ID: 24650035
    [Abstract] [Full Text] [Related]

  • 3. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L, Piao J, Gao W, Piao Y, Jin G, Ma Y, Li J, Lin Z.
    BMC Cancer; 2013 Jul 31; 13():366. PubMed ID: 23902796
    [Abstract] [Full Text] [Related]

  • 4. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
    Martinez-Useros J, Rodriguez-Remirez M, Borrero-Palacios A, Moreno I, Cebrian A, Gomez del Pulgar T, del Puerto-Nevado L, Vega-Bravo R, Puime-Otin A, Perez N, Zazo S, Senin C, Fernandez-Aceñero MJ, Soengas MS, Rojo F, Garcia-Foncillas J.
    BMC Cancer; 2014 Dec 16; 14():965. PubMed ID: 25515240
    [Abstract] [Full Text] [Related]

  • 5. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
    Datta A, Adelson ME, Mogilevkin Y, Mordechai E, Sidi AA, Trama JP.
    BMC Cancer; 2011 Jun 10; 11():234. PubMed ID: 21663673
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Tsai MM, Wang CS, Tsai CY, Huang CG, Lee KF, Huang HW, Lin YH, Chi HC, Kuo LM, Lu PH, Lin KH.
    Eur J Cancer; 2016 Sep 10; 64():137-48. PubMed ID: 27420607
    [Abstract] [Full Text] [Related]

  • 7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS, Wang YF, Zhang XQ, Lv JM, Li Y, Liu XX, Xu TP.
    Neoplasma; 2016 Sep 10; 63(2):223-30. PubMed ID: 26774144
    [Abstract] [Full Text] [Related]

  • 8. CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer.
    Wang J, Wen T, Li Z, Che X, Gong L, Jiao Z, Qu X, Liu Y.
    Aging (Albany NY); 2020 Nov 21; 13(2):1883-1897. PubMed ID: 33232276
    [Abstract] [Full Text] [Related]

  • 9. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
    Wang X, Lin L, Ren X, Lin Z, Li Z, Li C, Jin T.
    Int J Clin Exp Pathol; 2014 Nov 21; 7(8):5016-23. PubMed ID: 25197373
    [Abstract] [Full Text] [Related]

  • 10. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
    Huang M, He YR, Liang LC, Huang Q, Zhu ZQ.
    World J Gastroenterol; 2017 Sep 14; 23(34):6330-6338. PubMed ID: 28974900
    [Abstract] [Full Text] [Related]

  • 11. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
    Xu Z, Chen H, Yang B, Liu X, Zhou X, Kong H.
    Can J Gastroenterol Hepatol; 2019 Sep 14; 2019():3076345. PubMed ID: 31281803
    [Abstract] [Full Text] [Related]

  • 12. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
    Xiao Y, Xie J, Liu L, Huang W, Han Q, Qin J, Liu S, Jiang Z.
    J Clin Lab Anal; 2021 Feb 14; 35(2):e23652. PubMed ID: 33219617
    [Abstract] [Full Text] [Related]

  • 13. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J.
    BMC Cancer; 2018 Feb 06; 18(1):144. PubMed ID: 29409457
    [Abstract] [Full Text] [Related]

  • 14. DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.
    Çalışkaner ZO, Çakar T, Özçelik E, Özdilek A, Kim AS, Doğan Ö, Bosompem A, Grosveld G, Saka B, Kandilci A.
    PLoS One; 2017 Feb 06; 12(5):e0178025. PubMed ID: 28558048
    [Abstract] [Full Text] [Related]

  • 15. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X, Zou L, Yao Q, Zhang Y, Gan L, Tang L.
    Oncol Rep; 2017 Aug 06; 38(2):1035-1042. PubMed ID: 28627610
    [Abstract] [Full Text] [Related]

  • 16. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y, Yang B, Xi Y, Chen X.
    Tumour Biol; 2016 Nov 06; 37(11):14969-14978. PubMed ID: 27651161
    [Abstract] [Full Text] [Related]

  • 17. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
    Toiyama Y, Tanaka K, Kitajima T, Shimura T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, Ohi M, Inoue Y, Mohri Y, Goel A, Kusunoki M.
    Carcinogenesis; 2015 Dec 06; 36(12):1474-83. PubMed ID: 26420253
    [Abstract] [Full Text] [Related]

  • 18. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
    Chung HW, Kim JJ, Choi JI, Lee HR, Lim JB.
    Yonsei Med J; 2019 Aug 06; 60(8):713-719. PubMed ID: 31347325
    [Abstract] [Full Text] [Related]

  • 19. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
    Lee SY, Jung W, Lee J, Kim A, Kim HK, Kim BH.
    Histol Histopathol; 2019 Nov 06; 34(11):1279-1288. PubMed ID: 31066459
    [Abstract] [Full Text] [Related]

  • 20. DEK oncogene is overexpressed during melanoma progression.
    Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestín C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL.
    Pigment Cell Melanoma Res; 2017 Mar 06; 30(2):194-202. PubMed ID: 27893188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.